Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jun;27(3):145-53.
doi: 10.1007/s12250-012-3241-1. Epub 2012 Jun 9.

Developments of subunit and VLP vaccines against influenza A virus

Ma-ping Deng  1 , Zhi-hong Hu, Hua-lin Wang, Fei Deng
Affiliations
Review

Developments of subunit and VLP vaccines against influenza A virus

Ma-ping Deng et al. Virol Sin. 2012 Jun.

Abstract

Influenza virus is a continuous and severe global threat to mankind. The continuously re-emerging disease gives rise to thousands of deaths and enormous economic losses each year, which emphasizes the urgency and necessity to develop high-quality influenza vaccines in a safer, more efficient and economic way. The influenza subunit and VLP vaccines, taking the advantage of recombinant DNA technologies and expression system platforms, can be produced in such an ideal way. This review summarized the recent advancements in the research and development of influenza subunit and VLP vaccines based on the recombinant expression of hemagglutinin antigen (HA), neuraminidase antigen (NA), Matrix 2 protein (M2) and nucleocapsid protein (NP). It would help to get insight into the current stage of influenza vaccines, and suggest the future design and development of novel influenza vaccines.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Altstein A. D., Gitelman A. K., Smirnov Y. A., et al. Immunization with influenza a np-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses. Arch Virol. 2006;151(5):921–931. doi: 10.1007/s00705-005-0676-9. - DOI - PubMed
    1. Barefoot B. E., Sample C. J., Ramsburg E. A. Recombinant vesicular stomatitis virus expressing influenza nucleoprotein induces cd8 t-cell responses that enhance antibody-mediated protection after lethal challenge with influenza virus. Clin Vaccine Immunol. 2009;16(4):488–498. doi: 10.1128/CVI.00451-08. - DOI - PMC - PubMed
    1. Biesova Z., Miller M. A., Schneerson R., et al. Preparation, characterization, and immunogenicity in mice of a recombinant influenza h5 hemagglutinin vaccine against the avian h5n1 a/vietnam/1203/2004 influenza virus. Vaccine. 2009;27(44):6234–6238. doi: 10.1016/j.vaccine.2009.07.107. - DOI - PMC - PubMed
    1. Brands R., Visser J., Medema J., et al. Influvac: A safe madin darby canine kidney (mdck) cell culture-based influenza vaccine. Dev Biol Stand. 1999;98:93–100. - PubMed
    1. Brett I. C., Johansson B. E. Immunization against influenza a virus: Comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Virology. 2005;339(2):273–280. doi: 10.1016/j.virol.2005.06.006. - DOI - PubMed

Publication types

MeSH terms